Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02277912
Other study ID # TYH2013311
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2013
Est. completion date September 2016

Study information

Verified date October 2018
Source Helsinki University Central Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the analgesic effects of navigated repetitive transcranial magnetic stimulation in central post stroke pain. MRI based navigation is used to determine the exact locations for stimulation.


Description:

Central post stroke pain is often very resistant to treatment. TMS has been shown to be a promising tool in treating difficult pain conditions. The best sites for stimulation are still not known and navigation has been used only in few studies.

The aim is to evaluate the analgesic effects of Navigated Repetitive Transcranial Magnetic Stimulation ( nrTMS ) on pain in a three armed crossover study. The navigation is done by using magnetic resonance imaging and stereotactic camera system. The three arms include stimulation to M1, S2 and sham stimulation to M1. 10 Hz repetitive stimulation is given to a specified location once a day 5 days a week for two weeks in each of the three arms. A months washout period is kept between each arm of the study.

Pain and other variables are followed before, during and after the study for 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date September 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- MRI defined brain infarction or hemorrhage before or at the age of 65 years

- CPSP diagnostic criteria is met (definite), verified by a neurologist

- Stable analgesic medication

- Average pain NRS 4 or more

Exclusion Criteria:

- Epilepsy

- Difficult aphasia

- Dementia

- Contraindication for TMS or MRI

- Alcohol and/or drug abuse

Study Design


Related Conditions & MeSH terms


Intervention

Device:
navigated rTMS of motor cortex
Navigated repetitive transcranial magnetic stimulation of the motor cortex ( 10 Hz ) ,5 daily sessions per week for two weeks.
navigated rTMS of somatosensory cortex 2
Navigated repetitive transcranial magnetic stimulation of the secondary somatosensory cortex ( 10 Hz ), 5 daily sessions per week for two weeks
SHAM rTMS with SHAM block
Repetitive SHAM transcranial magnetic stimulation of the motor cortex ( 10Hz) 5 daily sessions per week for two weeks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Helsinki University Central Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Change in average pain compared to baseline Patients will keep a pain diary for one week before stimulation and for two weeks after the stimulation. A nurse will call the patient one month after the last stimulation. 1 month after each arm of the study
Secondary Quality of life (EQ-5D) Questionnaire EQ-5D One week after each arm of the study and 6 months after the last one
Secondary Depression Questionnaire One week after each arm of the study and 6 months after the last stimulation
Secondary Change in average pain compared to baseline Phone call ( Numeric Rating Scale (NRS) in rest and movement ) 2,3,4,5 and 6 months after the last stimulation
Secondary Magnetoencephalography (MEG) Changes in the irritability of the motor cortex and somatosensory cortex One week before and after each arms stimulations
Secondary Number of patients with adverse effects Adverse effects are followed actively From the start to the end of the study, on average 12 months per patient.
Secondary Hands´ motor function and dexterity Nine hole peg, Pinch and Jamar One week before and after each arm of the study
Secondary Cold water test Conditioned pain modulation (CPM) One week before and after each arm of the study
Secondary Genetics Evaluation of genetical properties in terms of TMS related pain reduction No time frame, just a blood sample
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06387914 - Efficacy of Pain Intervention With Deep Brain Stimulation Neuromodulation N/A
Completed NCT02148588 - Peripheral Sensory Input in Central Post Stroke Pain (CPSP) N/A